World's Best Scientists 2026 revealed!
Mark A. Wainberg

Mark A. Wainberg

Award Badge
Microbiology
Canada
2023

D-Index & Metrics

Microbiology

D-Index
96
Citations
38011
World Ranking
499
National Ranking
12

Medicine

D-Index
97
Citations
38692
World Ranking
9201
National Ranking
363

Mark A. Wainberg publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mark A. Wainberg sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 794 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mark A. Wainberg D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Wainberg sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 96 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Microbiology in Canada Leader Award
  • 2022 - Research.com Microbiology in Canada Leader Award
  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2000 - Fellow of the Royal Society of Canada Academy of Science

Overview

Mark A. Wainberg was affiliated with McGill University in Canada. Their research primarily focused on areas within Medicine and Immunology and Microbiology, with subfields including Infectious Diseases, Virology, and Emergency Medicine. The main topics covered in their work revolved around HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, and HIV/AIDS drug development and treatment.

They collaborated frequently with several co-authors throughout their career. Notable frequent collaborators included Leah Szadkowski, Curtis Cooper, Mona Loutfy, Alexander Wong, and Robert S. Hogg, each with multiple joint publications.

Mark A. Wainberg contributed papers to various scientific journals. Some of their recent publications included:

  • Increased CD4: CD8 ratio normalization with implementation of current ART management guidelines (2020), published in Journal of Antimicrobial Chemotherapy
  • ¿Es posible que se genere resistencia al dolutegravir cuando se utiliza este agente en el tratamiento de primera línea? (2023), published in Actualizaciones en Sida e Infectología

The scientist's work appeared in publication venues such as Journal of Antimicrobial Chemotherapy and Actualizaciones en Sida e Infectología. Their research contributed to advancements in understanding antiretroviral therapy guidelines and drug resistance concerns in HIV treatment.

In recognition of their scientific contributions, Mark A. Wainberg was named a Fellow of the Royal Society of Canada in 2000 and a Fellow of the American Association for the Advancement of Science (AAAS) in 2011.

Best Publications

  • On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

    Abstr Act;C. Capitant;B. Spire;G. Pialoux

  • A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

    Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella

  • High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

    Bluma G Brenner;Michel Roger;Jean-Pierre Routy;Daniela Moisi

  • Public health implications of antiretroviral therapy and HIV drug resistance.

    Mark A. Wainberg;Gerald Friedland

  • Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

    Jean-Michel Molina;Jean-Michel Molina;Isabelle Charreau;Bruno Spire;Laurent Cotte

  • High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.

    C. A. B. Boucher;N. Cammack;P. Schipper;R. Schuurman

  • Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase.

    Mark A. Wainberg;William C. Drosopoulos;Horacio Salomon;Mayla Hsu

  • A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

    Bluma Brenner;Dan Turner;Maureen Oliveira;Daniela Moisi

  • In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA.

    Mark A Wainberg;Michael D Miller;Yudong Quan;Horacio Salomon

  • Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog.

    H. Soudeyns;Xiao-Jian Yao;Qing Gao;B. Belleau

  • The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine.

    Qing Gao;Zhengxian Gu;M. A. Parniak;J. Cameron

  • Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.

    Janet M. Raboud;Julio S.G. Montaner;Brian Conway;Sandra Rae

  • Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance

    Shalom Spira;Mark A Wainberg;Hugues Loemba;Dan Turner

  • Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.

    Zhengxian Gu;Qing Gao;H. Fang;H. Salomon

  • Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.

    Z Gu;Q Gao;X Li;M A Parniak

  • CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.

    Zhen Wang;Zhen Wang;Qinghua Pan;Patrick Gendron;Weijun Zhu

  • HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture.

    Bluma G Brenner;Maureen Oliveira;Florence Doualla-Bell;Daniela D Moisi

  • Development of antiretroviral drug resistance.

    Mark A. Wainberg;Gerasimos J. Zaharatos;Bluma G. Brenner

  • Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir

    Peter K. Quashie;Thibault Mesplède;Ying-Shan Han;Maureen Oliveira

  • Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection.

    Bluma G. Brenner;Jean-Pierre Routy;Marco Petrella;Daniela Moisi

  • Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort

    Zachary Tanner;Nathan Lachowsky;Nathan Lachowsky;Erin Ding;Hasina Samji

Frequent Co-Authors

Bluma G. Brenner
Bluma G. Brenner McGill University
Chen Liang
Chen Liang McGill University
Lawrence Kleiman
Lawrence Kleiman McGill University
John Hiscott
John Hiscott Istituto Pasteur
Michael A. Parniak
Michael A. Parniak University of Pittsburgh
Jean-Pierre Routy
Jean-Pierre Routy McGill University Health Centre
Eric J. Arts
Eric J. Arts University of Western Ontario
Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia
Michel Roger
Michel Roger University of Montreal
Michel J. Tremblay
Michel J. Tremblay Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in exploring careers related to microbiology, several online degree options can expand your prospects. Students often look for a fast track medical billing and coding certificate online to enter the healthcare industry quickly with specialized skills. This pathway offers a practical bridge into the medical field without committing to years of schooling.

If you're considering broader healthcare roles, many online healthcare degrees that pay well are available. These programs provide flexibility and often lead to rewarding careers in fields where your microbiology background will be advantageous.

For those aiming to work in public health or epidemiology, enrolling in easy admission online MPH programs can be a practical choice. These programs emphasize disease prevention and control, complementing microbiology knowledge with essential public health skills.

Another unique career path linked to healthcare and child wellness is becoming a child life specialist. This role supports children’s emotional needs during medical treatments, making it a meaningful profession where scientific understanding and compassion meet.

Best Scientists Citing Mark A. Wainberg

Recently Published Articles